1.421 articles found

The effect of cardiovascular risk on disease progression in <i>de novo</i> Parkinson's disease patients: An observational analysis.

Oosterwegel MJ, Krijthe JH, den Brok MGHE, van den Heuvel L, Richard E, Heskes T, Bloem BR, Evers LJW.

Front Neurol · 2023-04-12

DOI: 10.3389/fneur.2023.1138546PMID: 37122316

Corrigendum: A progression analysis of motor features in Parkinson's disease based on the mapper algorithm.

Ma LY, Feng T, He C, Li M, Ren K, Tu J.

Front Aging Neurosci · 2023-03-28

DOI: 10.3389/fnagi.2023.1174022PMID: 37077502

Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis.

Zhong Q, Wang S.

Front Aging Neurosci · 2023-03-16

DOI: 10.3389/fnagi.2023.1109914PMID: 37009459

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease.

Olagunju AS, Ahammad F, Alagbe AA, Otenaike TA, Teibo JO, Mohammad F, Alsaiari AA, Omotoso O, Talukder MEK.

Heliyon · 2023-03-11

DOI: 10.1016/j.heliyon.2023.e14387PMID: 36942213

B lymphocyte responses in Parkinson's disease and their possible significance in disease progression.

Scott KM, Chong YT, Park S, Wijeyekoon RS, Hayat S, Mathews RJ, Fitzpatrick Z, Tyers P, Wright G, Whitby J, Barker RA, Hu MT, Williams-Gray CH, Clatworthy MR.

Brain Commun · 2023-03-09

DOI: 10.1093/braincomms/fcad060PMID: 36993946

Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson's disease.

Chan L, Chung CC, Yu RC, Hong CT.

Aging (Albany NY) · 2023-03-09

DOI: 10.18632/aging.204575PMID: 36897204

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease

Olagunju AS, Ahammad F, Alagbe AA, Otenaike TA, Teibo JO, Mohammad F, Alsaiari AA, Omotoso O, Talukder MEK.

Heliyon · 2023-03-01

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.

Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K, the Parkinson’s Progression Markers Initiative.

NPJ Parkinsons Dis · 2023-02-28

DOI: 10.1038/s41531-023-00468-2PMID: 36854767

Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy.

Abate F, Russo M, Ricciardi C, Tepedino MF, Romano M, Erro R, Pellecchia MT, Amboni M, Barone P, Picillo M.

Parkinsonism Relat Disord · 2023-02-24

DOI: 10.1016/j.parkreldis.2023.105345PMID: 36868037

Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism.

Jacob MA, Cai M, Bergkamp M, Darweesh SKL, Darweesh SKL, Gelissen LMY, Marques J, Norris DG, Duering M, Esselink RAJ, Tuladhar AM, de Leeuw FE.

Ann Neurol · 2023-02-23

DOI: 10.1002/ana.26615PMID: 36762437

A progression analysis of motor features in Parkinson's disease based on the mapper algorithm.

Ma LY, Feng T, He C, Li M, Ren K, Tu J.

Front Aging Neurosci · 2023-02-21

DOI: 10.3389/fnagi.2023.1047017PMID: 36896420

Altered Spinal Cord Functional Connectivity Associated with Parkinson's Disease Progression.

Landelle C, Dahlberg LS, Lungu O, Misic B, De Leener B, Doyon J.

Mov Disord · 2023-02-21

DOI: 10.1002/mds.29354PMID: 36802374